InnovHeart fetches Series B

Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing.

Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing. The investors included Genextra, Panakes Partners, CDP Venture Capital and Indaco Venture Partners.

Source: Press Release